Top Defensive Companies To Buy Right Now

German stocks fell, with the benchmark DAX (DAX) dropping to its lowest level in seven weeks, amid an unexpected decline in retail sales and uncertainty over potential U.S. military action against Syria.

Deutsche Lufthansa AG (LHA) and Allianz SE (ALV) led airlines and insurers lower, retreating at least 1.5 percent. Bayerische Motoren Werke AG (BMW) slid 1.6 percent. Deutsche Bank AG (DBK) rose after JPMorgan Chase & Co. boosted its recommendation on the shares. Gildemeister AG (GIL) added 3.4 percent after Deutsche Bank upgraded the maker of cutting tools.

The DAX declined 1.1 percent to 8,103.15 at the close of trading in Frankfurt, the lowest since July 10. The measure has dropped 3.7 percent this week and 2.1 percent this month amid speculation the Federal Reserve will reduce stimulus and concern the U.S. and its allies will strike against Bashar al-Assad�� government. The broader HDAX Index fell 1 percent today.

��e��l see a very defensive trading session because we��e got the long weekend ahead with U.S. stock exchanges closed on Monday,��said Andreas Lipkow, a senior market strategist at Kliegel & Hafner AG in Berlin. ��eople are trying to figure out what will happen in Syria. Market participants noticed the retail numbers but will be focused more on the Syria theme.��

Top 10 Trucking Stocks To Buy Right Now: Roche Holding AG (RHHBY)

Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. The Company belongs to the Roche Group that operates through numerous subsidiaries and associated companies located around the world. The Company�� products and services cover every stage of the healthcare process, from identifying disease susceptibilities and testing for disease in at-risk populations to prevention, diagnosis, therapy and treatment monitoring. Roche operates through two divisions: Pharmaceuticals and Diagnostics. Within the Pharmaceuticals Division there are three sub-divisions: Roche Pharmaceuticals, Genentech and Chugai. The Company�� Diagnostics Division includes five sub-divisions: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. Its activities are structured into six geographical segments: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan. In March 2009, the Company completed the acquisition of Genentech, Inc. In March 2010, the Company acquired assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.

During the year ended December 31, 2008, the Company Pharmaceuticals Division marketing gained approvals for its rheumatoid arthritis medicine Actemra/RoActemra in Japan, Switzerland and the European Union. In 2008, the division initiated 12 new phase III projects in, including clinical trials of the compounds pertuzumab, for breast cancer; taspoglutide, for type two diabetes, and dalcetrapib, for cardiovascular risk reduction. As of December 31, 2008, the Pharmaceuticals Division filed 11 major new marketing applications and gained 13 major regulatory approvals. At the beginning of 2009, the division�� research and development pipeline comprised 120 clinical projects, including 62 new molecular entities (NMEs) and 58 additional indications. Forty NMEs are in phase I, 16 in phase II and six in phase III or f! iled for regulatory review.

In 2008, Roche Pharmaceuticals signed a total of 57 new agreements including seven product transactions and 43 research and technology collaborations. In May 2008, Roche acquired Piramed Limited, a UK company with therapeutic research programmes targeting the PI3-kinase pathway in oncology and inflammatory disease. In June 2008, signed licensing agreement with ThromboGenics and BioInvent for their jointly developed anticancer agent TB-403 (R7334). In September, 2008, the Company acquired Mirus Bio Corporation active in the field of ribonucleic acid interference (RNAi) delivery and completed the acquisition of ARIUS Research Inc., which has a antibody platform that identifies and selects antibodies based on their functional ability to affect disease. S Research Inc. In January 2009, Roche acquired Memory Pharmaceuticals, which develops drug candidates for the treatment of debilitating central nervous system disorders such as Alzheimer�� disease and schizophrenia.

Pharmaceuticals

Within Pharmaceuticals division, the Company is engaged in the provision of drugs the areas of oncology, anemia, cardiovascular diseases, central nervous system, infectious diseases, inflammatory and autoimmune diseases, metabolic disorders, cancer, transplantation and virology. The products offered by Roche�� Pharmaceuticals division include MabThera/Rituxan, Herceptin, Avastin, Tamiflu, CellCept, NeoRecormon, Epogin, Pegasys, Tarceva, Xeloda, Bonviva, Boniva, Lucentis, Tamiflu, Xolair, Valcyte, Cymevene, Xenical, Pulmozyme, Nutropin, Neutrogin, Rocephin, Activase, TNKase and Madopar. The products offered by the Pharmaceuticals division are sold in seven geographic regions: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan.

Diagnostics

Roche�� Diagnostics Division is a supplier of in vitro diagnostics (IVDs). Its products are used to test body fluids a! nd tissue! samples to obtain information for the purpose of preventing, diagnosing, treating and monitoring disease. The Company has business areas five within the diagnostics division: Professional Diagnostics, Diabetes Care, Tissue Diagnostics, Molecular Diagnostics and Applied Science. Roche�� Diagnostics division provides IVD services, including centralized laboratory testing and point-of-care diagnostics to molecular diagnostics and diabetes self management. In addition, it supplies research tools to life scientists.

Roche Professional Diagnostics supplies instrument systems, tests, software and services. It provides point-of-care testing products to support clinical decision-making close to the patient, in doctors��offices, emergency rooms and other primary and specialty care settings. Twelve Serum Work Area assays were rolled out during the year ended December 31, 2008, across Europe and in other markets. New assays included the Elecsys anti-TSH receptor antibody assay for the diagnosis of Graves��disease the Elecsys anti-CCP antibody assay, a test to aid the diagnosis of rheumatoid arthritis, and the Roche Cystatin C clinical chemistry test for early detection of impaired kidney function, among others. Roche Diabetes Care�� products portfolio covers the entire diabetes self-management spectrum, from glucose monitoring to insulin delivery, as well as monitoring systems with integrated lancets and test strips software for storing and analyzing data. Roche Tissue Diagnostics develops and manufactures medical diagnostic instruments and reagent systems that provide automation technology for use in the diagnosis and prognosis of cancer and infectious disease. In 2008 Roche Tissue Diagnostics launched ofhe Bench- Mark Ultra, a system that performs immunohistochemistry and in situ hybridisation testing simultaneously on a single continuous and random access platform. Roche Molecular Diagnostics develops and commercializes diagnostic and blood screening platforms and tests based on Roche�� ! real-time! polymerase chain reaction (PCR) technology. Applied Science business area supplies a specific reagents and test kits for use in life sciences encompassing biology, biotechnology ,medical research, as well as disease areas like cancer and virology. Applied Science�� business area product portfolio includes such sequencing systems as LightCycler 480, LightCycler 480 II, GS FLX Titanium. In addition, Applied Science offers xCELLigence cell analyzer.

Advisors' Opinion:

• [By Maxx Chatsko]

  Anytime a megablockbuster nears the end of its IP-protected life, plenty of companies will emerge to get a piece of the pie. In this case,�Roche� (NASDAQOTH: RHHBY  ) has two megablockbusters with a combined $13.5 billion in 2012 sales coming off patent in the next several years. That is bad news for the innovator, but opens a big opportunity for the various companies targeting biosimilars. In fact, a total of 19 trials are under way to develop generic versions of Rituxan and Herceptin. In the following video, Fool contributor Maxx Chatsko tells investors which companies to keep an eye on in the race to unseat Roche.

Top Defensive Companies To Buy Right Now: AAR Corp.(AIR)

AAR CORP. provides products and services to aviation, government, and defense markets worldwide. The company?s Aviation Supply Chain segment purchases and sells new, overhauled, and repaired engine and airframe parts and components. It also repairs, overhauls, and sells avionics, electrical, electronic, fuel, hydraulic, and pneumatic components and instruments, as well as internal airframe components; and provides customized inventory supply and management programs for engine and airframe parts and components. In addition, this segment sells and leases commercial jet engines and used commercial aircraft; and provides advisory services, including assistance in remarketing aircraft, records management, and storage maintenance. Its Government and Defense Services segment involves in fixed- and rotary-wing flight operations; and performs engineering and design modifications on rotary-wing aircraft for government customers. This segment also provides customized performance-base d logistics programs in support of the U.S. Department of Defense and foreign governments; and engineering, design, manufacturing, and system integration services. The company?s Maintenance, Repair, and Overhaul segment provides airframe maintenance inspection and overhaul, painting, line maintenance, airframe modifications, structural repairs, avionic service and installation, exterior and interior refurbishment, and engineering services, as well as support for commercial and military aircraft; and repairs and overhauls landing gears, wheels, and brakes. Its Structures and Systems segment designs, manufactures, and repairs airdrop and other transportation pallets, and containers and shelters used in support of military and humanitarian tactical deployment activities. This segment also designs, manufactures, and installs in-plane cargo loading and handling systems for commercial and military aircraft and helicopters. AAR CORP. was founded in 1951 and is headquartered in Wood Dale, Illinois.

Advisors' Opinion:

• [By Ben Levisohn]

  AAR Corp. (AIR) has dropped 5.6% to $28.25 after it said it earned 45 cents a share, in line with analyst estimates, but sales missed.

  Landec (LNDC) has plunged 13% to $11.85 after it reported a profit of 18 cents a share, below forecasts for 23 cents.

• [By Jake L'Ecuyer]

  AAR (NYSE: AIR) shares tumbled 10.32 percent to $26.84 after the company reported a drop in its fiscal first-quarter profit.

  J. C. Penney Company (NYSE: JCP) was down, falling 15.17 percent to $10.10 despite a Dow Jones report stating that J.C. Penney will hire around 35,000 holiday season workers.

Top Defensive Companies To Buy Right Now: Cognex Corporation(CGNX)

Cognex Corporation provides machine vision products that capture and analyze visual information to automate tasks primarily in manufacturing processes. It operates in two divisions, Modular Vision Systems and Surface Inspection Systems. The Modular Vision Systems division develops, manufactures, and markets modular vision systems that are used to automate the manufacture of discrete items, such as cellular phones, aspirin bottles, and automobile wheels by locating, identifying, inspecting, and measuring them during the manufacturing process. The Surface Inspection Systems division develops, manufactures, and markets surface inspection vision systems that are used to inspect the surfaces of materials processed in a continuous fashion, including metals, papers, nonwoven, plastics, and glass. The company serves customers in factory automation, semiconductor and electronics capital equipment, and surface inspection markets. Cognex Corporation sells its products through direct sales force, as well as through a network of integration and distribution partners worldwide. The company was founded in 1981 and is headquartered in Natick, Massachusetts.

Advisors' Opinion:

• [By Garrett Cook]

  Shares of Cognex (NASDAQ: CGNX) got a boost, shooting up 14.94 percent to $43.45 after the company reported better-than-expected quarterly results and issued a strong Q3 revenue outlook.

Top Defensive Companies To Buy Right Now: Cigna Corp (CI)

Cigna Corporation (Cigna), incorporated on November 3, 1981, is a holding company. Cigna is a global health service company, with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services. In the United States, these products and services are offered through employers and other groups, and in selected international markets, Cigna offers supplemental health, life and accident insurance products and international health care coverage and services to businesses, governmental and non-governmental organizations and individuals. The Company also has certain run-off operations, including a Run-off Reinsurance segment. Cigna�� revenues are derived from premiums, fees, mail order pharmacy, other revenues and investment income. Cigna operates in five segments: Health Care, Disability and Life, International, Run-off Reinsurance, and Other Operations, including Corporate-owned Life Insurance. On January 31, 2012, Cigna acquired HealthSpring, Inc. On November 30, 2011, the Company acquired FirstAssist Group Holdings Limited. In August 2012, the Company acquired Great American Supplemental Benefits from American Financial Group, Inc. In January 2013, the Company acquired select Arcadian and Humana Medicare Advantage plans in Arkansas, Oklahoma and Texas. In September 2013, Cigna Corporation completed its acquisition of Alegis Care, a portfolio company of Triton Pacific Capital Partners. Effective September 3, 2013, Cigna Corp acquired Home Physicians Management LLC.

Health Care

Cigna�� Health Care segment (Cigna HealthCare) offers insured and self-insured medical, dental, behavioral health, vision, and prescription drug benefit plans, health advocacy programs and other products and services that may be integrated to provide health care benefit programs. Cigna HealthCare companies offer these products and services in all 50 states, the District of Columbia and the United States Virgin Islands. Cigna offers a ! range of products and services to employers and other groups that sponsor group health plans. With the exception of Health Maintenance Organization (HMO), Medicare, Voluntary and stop loss products, each of Cigna HealthCare�� products is offered with alternative funding options. Cigna may sell multiple products under the same funding arrangement to the same employer. Approximately 85% of the Company�� medical customers are enrolled in self-insured plans, with the remainder split between guaranteed cost and experience-rated insured plans. Approximately 90% of its medical customers are enrolled in self-insured and experience-rated plans. Cigna also offers guaranteed cost medical and dental insurance to individuals. Cigna HealthCare offers a product line of indemnity managed care benefit plans on an insured (guaranteed cost or experience-rated) or self-insured basis. The Network, Network Open Access, and Open Access Plus In-Network products cover only those services provided by Cigna HealthCare participating health care professionals (in-network) and emergency services provided by non-participating health care professionals (out-of-network). The Network point of service (POS), Network POS Open Access and Open Access Plus plans (OAP) cover health care services provided by participating, and non-participating health care professionals.

Cigna HealthCare offers a Preferred Provider Plans (PPO) product line that features a national network. Like Network and Open Access Plus Plans, the PPO product line is offered on an insured (guaranteed cost or experience-rated) or self-insured basis. Cigna HealthCare offers the Cigna Choice Fund suite of products, including Health Reimbursement Accounts (HRA), Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA). Cigna HealthCare offers stop loss insurance coverage for self-insured plans. This stop loss coverage reimburses the plan for claims in excess of a predetermined amount, either for individuals (specific) or the entire group (aggregate), ! or both. ! Cigna HealthCare provides Taft-Hartley trusts and other entities access to its national provider network and provides claim re-pricing and other services. Cigna HealthCare�� voluntary medical products are offered to employers with 51 or more eligible employees. As a result of the acquisition of HealthSpring, Cigna operates Medicare Advantage coordinated care plans in 11 states and the District of Columbia. Under the Medicare program, Medicare-eligible beneficiaries may receive health care benefits, including prescription drugs, through a managed care health plan, such as the Company�� coordinated care plans, and The Centers for Medicare and Medicaid Services reimburse the Company pursuant to a risk adjustment payment methodology.

Cigna�� Medicare Part D prescription drug program, Cigna Medicare Rx, provides a number of plan options, as well as service and information support to Medicare and Medicaid eligible customers. Cigna Medicare Rx is available in all 50 states and the District of Columbia. Cigna HealthCare offers medical management, disease management, and other health advocacy services to employers and other plan sponsors. These services are offered to customers covered under Cigna HealthCare administered plans, as well as individuals covered under plans insured and/or administered by competing insurers/third-party administrators. Cigna�� onsite services include more than 75 health centers and the annual administration of more than 400,000 biometric screenings, as well as approximately 2,200 wellness seminars each year. As a result of the acquisition of HealthSpring, Cigna operates three LivingWell Health Centers, where Medicare customers can receive care from physicians, nurse practitioners, nurses, pharmacists, and nurses educators. Cigna arranges for behavioral health care services for customers through its network of participating behavioral health care professionals. Cigna offers behavioral health care case management services, employee assistance programs (EAP), and wor! k/life pr! ograms to employers, Government entities and other groups sponsoring health benefit plans. As of December 31, 2011, Cigna�� behavioral national network had approximately 108,000 access points to psychiatrists, psychologists and clinical social workers and approximately 9,000 facilities and clinics.

Cigna Pharmacy Management offers prescription drug plans to its insured and self-funded customers both in conjunction with its medical products and on a stand-alone basis. With a network of over 62,000 contracted pharmacies, Cigna Pharmacy Management is a pharmacy benefits manager (PBM) offering clinical integration programs, specialty pharmacy solutions and home delivery of prescription medicines. Cigna�� specialty pharmacy outcome management program, TheraCare, manages specialty conditions. TheraCare is coordinated with other Cigna health advocacy programs and all data is captured for analysis and reporting. Cigna Dental Health offers a variety of dental care products, including dental health maintenance organization plans (Dental HMO), dental preferred provider organization (DPPO) plans, dental exclusive provider organization plans, traditional dental indemnity plans and a dental discount program. As of December 31, 2011, Cigna Dental Health customers totaled approximately 10.9 million. Managed dental care products are offered in 38 states for Dental HMO and 43 states and the District of Columbia for Dental PPO through a network of independent health care professionals that have contracted with Cigna Dental Health to provide dental services. Cigna Dental Health customers access care from the dental PPO network in the United States and one of the dental HMO networks in the United States, with approximately 235,500 DPPO-contracted access points (approximately 92,000 health care professionals) and approximately 58,000 dental HMO-contracted access points (approximately 16,500 health care professionals).

Disability and Life

Cigna�� Disability and Life segment (Cign! a Disabil! ity and Life) provides insurance products and their related services, such as group long-term and short-term disability insurance, group life insurance and accident and specialty insurance. These products and services are provided by subsidiaries of Cigna Corporation. Cigna Disability and Life markets products in all 50 states, the District of Columbia, Puerto Rico, the United States Virgin Islands and Canada. Cigna Disability and Life also provides assistance to employees in returning to work and assistance to their employers in managing the cost of employee disability. Cigna Disability and Life offers personal accident insurance coverage, which consists primarily of accidental death and dismemberment and travel accident insurance to employers. Group accident insurance may be employer-paid or employee-paid. Cigna Disability and Life also offers specialty insurance services that consist primarily of disability and life, accident, and hospital indemnity products to professional or trade associations and financial institutions.

International

CIGNA�� International segment (CIGNA International) offers supplemental health, life and accident insurance products, as well as international health care products and services. These products and services are provided by subsidiaries of Cigna Corporation, including foreign operating entities. Cigna International provides employers, affinity groups and individuals with local and global health care and related financial protection programs. Supplemental health products provide a specified payment for a range of health risks and include personal accident, accidental death, critical illness, hospitalization, travel, dental, cancer and other dread disease coverages. Term life, as well as variable universal life insurance and other savings products are also included in the product portfolio. Cigna International�� supplemental health, life and accident insurance products are offered in South Korea, Taiwan, Indonesia, Hong Kong, the European Un! ion, Chin! a, New Zealand, Thailand and Turkey. In China, Cigna International owns a 50% interest in a joint venture through, which its products and services are offered. Cigna International�� health care businesses primarily consist of products and services to meet the needs of local and multinational companies and organizations and their local and globally mobile employees and dependents. These products and services include insurance and administrative services for medical, dental, vision, life, accidental death and dismemberment, and disability risks. In addition, Cigna International�� health care businesses include products and services, which are primarily provided through group benefits programs to employees of businesses and other organizations in the United Kingdom and Spain. These products and services include medical indemnity insurance coverage, with some offerings having managed care or administrative service aspects.

Run-off Reinsurance

Cigna�� reinsurance segment reinsured guaranteed minimum death benefits (GMDB) (also known as variable annuity death benefits (VADBe)), under certain variable annuities issued by other insurance companies. These variable annuities are investments in mutual funds combined with a death benefit. The Company purchased retrocessional protection that covers approximately 5% of the assumed risks. The Company also maintains a dynamic hedge program. Cigna also reinsured guaranteed minimum income benefits (GMIB) under certain variable annuities issued by other insurance companies. These variable annuities are investments in mutual funds combined with minimum income and death benefits. These products under Cigna�� Run-off Reinsurance segment were sold principally in North America and Europe through a sales force and through intermediaries.

Other Operations

The principal products of the Corporate-owned Life Insurance (COLI) business are permanent insurance contracts sold to corporations to provide coverage on the lives ! of certai! n employees for the purpose of funding employer-paid future benefit obligations. The principal services provided by the COLI business are issuance and administration of the insurance policies. COLI policies provide a death benefit for which Cigna collects fees to cover mortality risk. COLI policies also allow policy owners to borrow against a portion of their cash surrender value.

Advisors' Opinion:

• [By Ben Levisohn]

  United’s disappointment has helped drag down other health insurers. WellPoint (WLP) dropped 1.3% to $88.53, Health Net (HNT) has fallen 1.7% to $31.25, Aetna (AET) has declined 2.4% to $64.11 and Cigna (CI) is off 3.5% at $77.69.

• [By Sean Williams]

  For the insurers themselves, it would be a bit of a mixed bag. On one hand, the big three insurers that reached into their pockets and spent a fortune in the wake of Obamacare's passing --�WellPoint (NYSE: WLP  ) with its purchase of Amerigroup, Cigna� (NYSE: CI  ) with its purchase of HealthSpring, and Aetna (NYSE: AET  ) buying Coventry Health Care -- will be left waiting even longer for their membership numbers to rise. No enforceable mandate means enrollment figures will only marginally move higher in a best-case scenario.

• [By Sean Williams]

  Keep in mind, though, that WellPoint isn't the only insurer that's angling for these Medicaid members. CIGNA (NYSE: CI  ) paid a hefty sum of $3.8 billion to buy Healthspring in 2011 and Aetna (NYSE: AET  ) is purchasing Coventry Health Care (NYSE: CVH  ) for $5.7 billion all with the intent of garnering the guaranteed money associated with Medicaid. Don't be surprised if these insurers form alliances as well to promote Obamacare in order to serve their own interests in gaining new members.

Top Defensive Companies To Buy Right Now: EnerNOC Inc (ENOC)

EnerNOC, Inc. (EnerNOC), incorporated on June 5, 2003, is a provider of energy management applications, services and products for the smart grid, which include demand response, data-driven energy efficiency, and energy price and risk management applications, services and products. The Company�� energy management applications, services and products enable energy management strategies for commercial, institutional and industrial end-users of energy, which it refers to as its C&I customers, and its electric power grid operator and utility customers by reducing real-time demand for electricity, increasing energy efficiency and improving energy supply transparency. The Company�� energy management applications, services and products include its EnerNOC EfficiencySMART and SupplySMART applications and services, and certain wireless energy management products.

DemandSMART

The Company�� demand response capacity provides an alternative to building conventional supply-side resources, such as natural gas-fired peaking power plants, to meet periods of peak electricity demand. The Company is in the development, implementation and broader adoption of technology-enabled demand response services for the smart grid. The Company�� DemandSMART application enables us to send control signals to, and receive bi-directional communications from, an Internet-enabled network of dispersed C&I customer sites in order to initiate, monitor and complete demand response activity. The Company�� technology and operational processes have the ability to automate demand response and simplify C&I customer participation by remotely reducing electricity usage in a matter of minutes, or send curtailment instructions to its C&I customers to be manually implemented on site. The devices that it installs at its C&I customer sites transmit to us through the cellular network and Internet near real-time electrical consumption data on a 1-minute, 5-minute, 15-minute or hourly basis. The Company�� DemandSMART app! lication analyzes the data from individual sites and aggregates data for specific regions. When a demand response event occurs, its network operations center (NOC) automatically processes the notification coming from the electric power grid operator or utility. The Company�� NOC operators then begin activating procedures to curtail demand from the grid at its C&I customer sites.

The Company provides its demand response services to electric power grid operators and utilities under long-term contracts and pursuant to open market bidding programs. The Company�� long-term contracts generally have terms of 3-10 years and predetermined capacity commitment and payment levels. Within these contracts and open market programs, it offers the services to address the needs of electric power grid operators and utilities: reliability-based demand response, price-based demand response, and short-term reserve resources referred to in the electric power industry as ancillary services.

EfficiencySMART

EfficiencySMART is the Company�� data-driven energy efficiency suite that includes energy efficiency planning, audits, assessments, commissioning and retro-commissioning authority services, and a cloud-based energy analytics application used for managing energy across a C&I customer�� portfolio of sites. The cloud-based energy analytics application also includes the ability to integrate with a C&I customer�� existing energy management system, provide utility bill management and tools for measurement, tracking, analysis, reporting and management of greenhouse gas emissions. The Company offers the EfficiencySMART applications and services, which include EfficiencySMART Plan, EfficiencySMART Audit, EfficiencySMART Assessment, EfficiencySMART Commissioning and EfficiencySMART Insight.

EfficiencySMART Plan provides its C&I customers with a multi-year profile of projected energy demand, consumption and costs, including a lifecycle financial analysis of potential energy! strategi! es and a roadmap for implementation. EfficiencySMART Audit provides its C&I customers with energy efficiency recommendations in compliance with the American Society of Heating, Refrigeration and Air-Conditioning (ASHRAE) standards for conditioned space, and tactical energy surveys for industrial facilities. EfficiencySMART Assessment provides detailed recommendations for energy savings, demand reductions, reductions in energy intensity through operation and maintenance activities, equipment retrofits, behavioral changes, or the use of new technologies. EfficiencySMART Commissioning includes traditional and/or new building commissioning services, such as investigation, testing and verification of energy efficiency strategies, and data analytics over a specified period of time. EfficiencySMART Insight provides its large, multi-site C&I customers with a Software-as-a-Service enterprise energy management solution that provides persistent commissioning with the ability to visualize near real-time energy usage, identify savings opportunities, and prioritize energy-related investments across a portfolio of meters and buildings across a C&I customer�� organization.

SupplySMART

SupplySMART is the Company�� energy price and risk management application that provides its C&I customers located in restructured or deregulated markets throughout the United States with the ability to more effectively manage the energy supplier selection process, including energy supply product procurement and implementation. SupplySMART provides a framework for developing and implementing risk management strategies and executing purchasing strategies that provides maximum price transparency and structural savings on an ongoing basis for its C&I customers.

Technology and Operations

The Company�� technology has been developed provides a platform on which to design, customize, and implement its energy management applications, services and products. The Company�� technology infrast! ructure i! s built on Linux, Java and Oracle, and supports open Web services architecture. The Company�� enterprise energy management application platform enables the Company to efficiently scale its DemandSMART, EfficiencySMART, and SupplySMART applications and services, as well as certain wireless energy management products, in new geographic regions and rapidly grow the number of C&I customers in its network. The Company�� energy management application platform leverages Web services and wireless technologies that connect applications directly with other applications through a form of loose coupling, which allows connections to be established across applications without customization.

Network Operations Center

The Company�� technology enables its NOC to automatically respond to signals sent by electric power grid operators and utilities to deliver demand reductions within targeted geographic regions. The Company can customize its technology to receive and interpret many types of dispatch signals sent directly from an electric power grid operator or utility customer to its NOC. Following the receipt of such a signal, its NOC automatically notifies specified C&I customer personnel of the demand response event. After relaying this notification to its C&I customers, it initiate processes that reduce their electricity consumption from the electric power grid. These processes may include dimming lights, shifting equipment to power save mode, adjusting heating and cooling set points and activating a back-up generator. Demand reduction is monitored remotely with near real-time data feeds, the results of which are displayed in its NOC through various data presentment screens.

Energy Management Platform

The Company�� energy management platform is consists of its cloud-based enterprise software platform used for DemandSMART, EfficiencySMART and SupplySMART, as well as wireless energy management products and technology, and is the underlying system that runs its ! NOC. It u! tilizes a modular Web services architecture that is designed to allow application modules to be easily integrated into the platform. The Company use its energy management platform to measure, manage, benchmark and optimize C&I customers��energy consumption and facility operations. The Company use this data to help C&I customers analyze consumption patterns, forecast demand, measure real-time performance during demand response events, continuously monitor building management equipment to optimize system operation, model rates and tariffs and create energy scorecards to benchmark similar facilities. In addition, its energy management application platform has the ability to track its C&I customers��greenhouse gas emissions by mapping their energy consumption with the fuel mix used for generation in their location, such as the proportion of coal, nuclear, natural gas, fuel oil and other sources used.

The EnerNOC Site Server

The Company designs and installs a small device, called an EnerNOC Site Server, or ESS, at each C&I customer site to collect and communicate to its platform near real-time electricity consumption data and, in certain cases, enable remote control of a C&I customer�� electricity consumption. The ESS communicates to its NOC through the C&I customer�� LAN or secure Internet connection. The ESS is an open, integrated system consisting of a central hardware device residing inside a standard electrical box. The ESS allows its C&I customers to, among other things, respond quickly and completely to instructions from us to reduce electricity consumption. The Company also supports OpenADR protocol on its most recent ESS devices, an emerging standard for automated demand response communications.

The Company competes with Comverge, Inc., Exelon Corporation, Energy Curtailment Specialists and Hess, Inc., as well as energy technology providers Lucid Design Group, Inc., Building IQ, SCIEnergy, Inc. and McKinstry Co., LLC.

Advisors' Opinion:

• [By Dan Caplinger]

  Next Monday, EnerNOC (NASDAQ: ENOC  ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.

• [By Chris Hill]

  Shares of EnerNoc (NASDAQ: ENOC  ) and Exelon (NYSE: EXC  ) lose energy in the wake of analyst downgrades. Netflix (NASDAQ: NFLX  ) falls after releasing the fourth season of Arrested Development. And Beazer Homes (NYSE: BZH  ) benefits from rising home prices. In this installment of Investor Beat, our analysts discuss four stocks making moves.

• [By Rich Smith]

  Boston, Mass.-based EnerNOC (NASDAQ: ENOC  ) has a new chief financial officer.

  On Tuesday, the energy "smartgrid" software maker announced that it has hired Neil Moses, until March the chief global strategy officer for Dunkin' Brands (NASDAQ: DNKN  ) �and onetime CFO, as its new CFO.

• [By Alyce Lomax]

  After surging in recent months, EnerNOC (NASDAQ: ENOC  ) shares have sputtered out again. Developments concerning a major customer underline the evolving landscape for a company like this one. Right now, investors aren't exhibiting much demand for this demand response company.

Top Defensive Companies To Buy Right Now: Mercury General Corporation (MCY)

Mercury General Corporation, together with its subsidiaries, engages in writing personal automobile insurance products. The company also writes homeowners, commercial automobile and property, mechanical breakdown, fire, and umbrella insurance products. Its insurance products cover collision, property damage liability, bodily injury liability, comprehensive, personal injury protection, underinsured and uninsured motorist, and other hazards for automobile policy holders. The company sells its policies through a network of independent agents in California, Florida, Georgia, Illinois, Texas, Oklahoma, New York, New Jersey, Virginia, Pennsylvania, Arizona, Nevada, and Michigan. Mercury General Corporation was founded in 1960 and is headquartered in Los Angeles, California.

Advisors' Opinion:

• [By Fredrik Arnold]

  Ten Champion dogs that promised the biggest dividend yields into July included firms representing five of nine market sectors. The top stocks were three of five from the financial sector: Universal Health Realty Trust (UHT); Mercury General Corp. (MCY); Old Republic Int'l (ORI). The other two financial firms, HCP Inc., and United Bankshares Inc. (UBSI), placed sixth and eighth.

• [By John Udovich]

  Auto sales are booming and that�� good news for large cap auto insurer�the Progressive Corporation (NYSE: PGR) along with small cap auto insurers Safety Insurance Group, Inc (NASDAQ: SAFT) and�Mercury General Corporation (NYSE: MCY) as they offer income to yield hungry investors as well as income in the form of dividends. Specifically, a Yahoo! Autos blog recently noted that last month, automakers sold 1.5 million new vehicles for the highest rate in years with�most industry forecasters expecting sales to�return to the level they hit before the 2008 recession of 16 million vehicles a year. The blog post then went on to note the three forces driving auto sales:

• [By Chuck Carnevale] their website:

  ��ercury General (NYSE-MCY) is the leading independent broker and agency writer of automobile insurance in California and has been one of the fastest growing automobile insurers in the nation. It is ranked as the third largest private passenger automobile insurer in California, with total assets over $4 billion. Mercury also writes automobile insurance in Arizona, Florida, Georgia, Illinois, Michigan, Nevada, New Jersey, New York, Oklahoma, Pennsylvania, Texas and Virginia. In addition to automobile insurance, Mercury writes other lines of insurance in various states, including mechanical breakdown and homeowners insurance.��/p>

  [ Enlarge Image ]

  Performance and Dividends Impacted by Operating Stress

  It should be clear from the above graphs that the earnings records of these three Dividend Champions have been far from steady, consistent or reliable. Therefore, I cannot get comfortable either recommending them or investing in them because I cannot get comfortable predicting what their future operating results may be. Furthermore, by examining the performance results associated with the above earnings and price-correlated graphs illustrates a lot of uncertainty. A focus on the earnings growth rate column illustrates a lot of stress on each company�� ability to keep their dividend streaks alive (Blue Circles).

  [ Enlarge Image ]

  [ Enlarge Image ]

  [ Enlarge Image ]

  The Overvaluation Rejection

  Other reasons besides irregular earnings growth that caused a Dividend Champion to be rejected include one of my all-time favorites, valuation. Or to be more precise ��overvaluation. The following example, McCormick & Co. (MKC), represents one of my favorite Dividend Champions based on a very consistent above-average record of earnings growth that produced its impressive dividend streak. The only reason that this Dividend Champion was rejected was because of current overvaluation.

  [ Enlarge Imag